Log In
BCIQ
Print this Print this
 

Restylane Lyft (formerly Perlane-L)

  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionHyaluronic acid dermal filler plus 0.3% lidocaine
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationScars / wrinkles
Indication DetailsCorrect moderate to severe facial folds and wrinkles, such as nasolabial folds, and for subcutaneous to supraperiosteal implantation to augment cheeks and correct age-related midface contour deficiencies in adults; Correct moderate to severe facial wrinkles and folds
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1,400.0M

$1,400.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/28/2014

$1,400.0M

$1,400.0M

0

Get a free BioCentury trial today